SPC Logo

Privigen 100mg/ml solution for infusion

Last Updated on eMC 28-Mar-2014 View document  | CSL Behring UK Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28-Mar-2014 and displayed until Current

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 4 - possible side effects
  • Change to other sources of information section

Updated on 06-Nov-2013 and displayed until 28-Mar-2014

Reasons for adding or updating:

  • Change to section 6 - date of revision

Updated on 17-Oct-2013 and displayed until 06-Nov-2013

Reasons for adding or updating:

  • Change to section 6 - what the product looks like and pack contents

Updated on 19-Apr-2013 and displayed until 17-Oct-2013

Reasons for adding or updating:

  • Change to section 4 - possible side effects

Updated on 28-Mar-2013 and displayed until 19-Apr-2013

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 2 - excipient warnings
  • Change to section 3 - dose and frequency
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals

Updated on 21-Mar-2013 and displayed until 28-Mar-2013

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 2 - excipient warnings
  • Change to section 3 - dose and frequency
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals

Updated on 02-Apr-2012 and displayed until 21-Mar-2013

Reasons for adding or updating:

  • Change to information for healthcare professionals
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Removal of Black Triangle

Updated on 03-Aug-2011 and displayed until 02-Apr-2012

Reasons for adding or updating:

  • Change to Further Information section

Updated on 15-Mar-2011 and displayed until 03-Aug-2011

Reasons for adding or updating:

  • Extra statutory information

Updated on 31-Jan-2011 and displayed until 15-Mar-2011

Reasons for adding or updating:

  • Extra statutory information

Updated on 16-Sep-2010 and displayed until 31-Jan-2011

Reasons for adding or updating:

  • Change/addition of instructions for reconstitution and/ or administration
  • Change to information for healthcare professionals
  • Change to date of revision
  • Change to warnings or special precautions for use

Updated on 23-Apr-2010 and displayed until 16-Sep-2010

Reasons for adding or updating:

  • Correction of spelling/typing errors
  • Change to information for healthcare professionals

Updated on 12-Jun-2009 and displayed until 23-Apr-2010

Reasons for adding or updating:

  • Introduction of new pack/pack size

Updated on 17-Feb-2009 and displayed until 12-Jun-2009

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 17-Dec-2008 and displayed until 17-Feb-2009

Reasons for adding or updating:

  • New PIL for new product

Company contact details

CSL Behring UK Limited

Company image
Address

Hayworth House, Market Place, Haywards Heath, West Sussex, RH16 1DB, UK

Fax

+44 (0)1444 447 403

Medical Information e-mail
Out of Hours contact

+44 (0)1444 447 405

Telephone

+44 (0)1444 447 400

Medical Information Direct Line

+44 (0)1444 447 405

Customer Care direct line

+44 (0)1444 447 402

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

human normal immunoglobulin

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.